9 research outputs found

    Genome editing for low acrylamide wheat

    Get PDF
    Acrylamide (C3H5NO) is a food processing contaminant that has been classed as a probable (Group 2a) human carcinogen. Acrylamide forms from the reaction of free (non-protein) asparagine with reducing sugars during food processing. All major cereal products are affected and wheat products represent one of the main sources of dietary acrylamide intake in Europe. Asparagine concentration is the determining factor for acrylamide formation in cereal products. Asparagine biosynthesis is catalysed by a family of enzymes called asparagine synthetases (ASNs). The ASN genes were investigated and five ASN genes (TaASN1-4, with a double copy of TaASN3) identified in wheat (Triticum aestivum), with TaASN2 showing grain-specific expression. CRISPR/Cas9 was used to knock out the TaASN2 gene of wheat cv. Cadenza. A polycistronic gene containing four gRNAs, interspaced with tRNAs, was designed and introduced into wheat embryos by particle bombardment. The subsequent edits were characterised in the T1 and T2 generations using Next Generation Sequencing nucleotide sequence analysis. Triple (A, B, and D genome) nulls were identified, alongside an AD and an A genome null. Amino acid concentrations were measured in the T2 and T3 seed, with one triple null line showing a substantial reduction in the free asparagine concentration in the grain (90 % in the T2 seed and 50 % in the T3 seed compared with wildtype). The free asparagine also reduced as a proportion of the total free amino acid pool. Significant effects were also seen in glutamate and aspartate concentrations. Free asparagine and total free amino acid concentrations were higher in the T3 than T2 seeds, probably due to heat stress, but the concentrations in the edited plants remained substantially lower than in wildtype. Some of the edited lines showed poor germination, but this could be overcome by application of exogenous asparagine and no other phenotype was noted

    Cereal asparagine synthetase genes

    No full text
    Asparagine synthetase catalyses the transfer of an amino group from glutamine to aspartate to form glutamate and asparagine. The accumulation of free (non-protein) asparagine in crops has implications for food safety because free asparagine is the precursor for acrylamide, a carcinogenic contaminant that forms during high-temperature cooking and processing. Here we review publicly-available genome data for asparagine synthetase genes from species of the Pooideae subfamily, including bread wheat and related wheat species (Triticum and Aegilops spp.), barley (Hordeum vulgare) and rye (Secale cereale) of the Triticeae tribe. Also from the Pooideae subfamily: brachypodium (Brachypodium dystachion) of the Brachypodiae tribe. More diverse species are also included, comprising sorghum (Sorghum bicolor) and maize (Zea mays) of the Panicoideae subfamily, and rice (Oryza sativa) of the Ehrhartoideae subfamily. The asparagine synthetase gene families of the Triticeae species each comprise five genes per genome, with the genes assigned to four groups: 1, 2, 3 (subdivided into 3.1 and 3.2) and 4. Each species has a single gene per genome in each group, except that some bread wheat varieties (genomes AABBDD) and emmer wheat (Triticum dicoccoides; genomes AABB) lack a group 2 gene in the B genome. This raises questions about the ancestry of cultivated pasta wheat and the B genome donor of bread wheat, suggesting that the hybridisation event that gave rise to hexaploid bread wheat occurred more than once. In phylogenetic analyses, genes from the other species cluster with the Triticeae genes, but brachypodium, sorghum and maize lack a group 2 gene, while rice has only two genes, one group 3 and one group 4. This means that TaASN2, the most highly expressed asparagine synthetase gene in wheat grain, has no equivalent in maize, rice, sorghum or brachypodium. An evolutionary pathway is proposed in which a series of gene duplications gave rise to the five genes found in modern Triticeae species

    The Virtual Care Experience of Patients Diagnosed With COVID-19

    No full text
    Virtual models of care are seen as a sustainable solution to the growing demand for health care. This paper analyses the experience of virtual care among patients diagnosed with COVID-19 in home isolation or health hotel quarantine using a patient-reported experience questionnaire. Results found that patients respond well to virtual models of care during a pandemic. Lessons learned can inform future developments of virtual care models
    corecore